First Ebola Vaccine Moves Closer to Licensing, with Help of UF Researchers
The European Medicines Agency, or EMA, has announced its conditional marketing authorization of a vaccine used to prevent the spread of the Ebola virus. University of Florida researchers played an integral role in the design and analysis of trials testing the effectiveness of the vaccine, manufactured by Merck. Conditional authorization…